PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,684,208 | -21.2% | 743,873 | +0.0% | 0.00% | -20.0% |
| Q2 2023 | $9,748,427 | +20.2% | 743,587 | +2.5% | 0.01% | +25.0% |
| Q1 2023 | $8,111,442 | +32.7% | 725,532 | +0.1% | 0.00% | +33.3% |
| Q4 2022 | $6,110,705 | -49.6% | 724,876 | -0.4% | 0.00% | -57.1% |
| Q3 2022 | $12,130,000 | +29.0% | 728,057 | +14.0% | 0.01% | +40.0% |
| Q2 2022 | $9,402,000 | -30.6% | 638,727 | +17.0% | 0.01% | 0.0% |
| Q1 2022 | $13,539,000 | +1.1% | 545,711 | +30.7% | 0.01% | 0.0% |
| Q4 2021 | $13,388,000 | -11.3% | 417,457 | -0.4% | 0.01% | -16.7% |
| Q3 2021 | $15,086,000 | -19.0% | 419,290 | -0.6% | 0.01% | -14.3% |
| Q2 2021 | $18,616,000 | +90.1% | 421,947 | +97.1% | 0.01% | +75.0% |
| Q1 2021 | $9,793,000 | -33.6% | 214,101 | +0.2% | 0.00% | -33.3% |
| Q4 2020 | $14,747,000 | – | 213,665 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |